| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |